Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $168K | +1.8K | +25.78% | $93.50 | 8.78K | Dec 16, 2024 | Direct | |
transaction | ABBV | Common Stock, $0.01 par value | Sale | -$310K | -1.8K | -20.49% | $172.24 | 6.98K | Dec 16, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Option (Right to buy) | Options Exercise | -$168K | -1.8K | -12.94% | $93.50 | 12.1K | Dec 16, 2024 | Common Stock | 1.8K | $93.50 | Direct | F1 |
Id | Content |
---|---|
F1 | Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |